Fulgent Genetics Share Holder Equity 2015-2026 | FLGT
Fulgent Genetics share holder equity from 2015 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
|
Fulgent Genetics Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $1,107 |
| 2024 | $1,129 |
| 2023 | $1,133 |
| 2022 | $1,270 |
| 2021 | $1,166 |
| 2020 | $569 |
| 2019 | $83 |
| 2018 | $51 |
| 2017 | $54 |
| 2016 | $54 |
| 2015 | $5 |
| 2014 | $2 |
|
Fulgent Genetics Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $1,121 |
| 2025-06-30 | $1,112 |
| 2025-03-31 | $1,123 |
| 2024-12-31 | $1,129 |
| 2024-09-30 | $1,135 |
| 2024-06-30 | $1,129 |
| 2024-03-31 | $1,127 |
| 2023-12-31 | $1,133 |
| 2023-09-30 | $1,262 |
| 2023-06-30 | $1,263 |
| 2023-03-31 | $1,269 |
| 2022-12-31 | $1,270 |
| 2022-09-30 | $1,281 |
| 2022-06-30 | $1,311 |
| 2022-03-31 | $1,313 |
| 2021-12-31 | $1,166 |
| 2021-09-30 | $1,044 |
| 2021-06-30 | $921 |
| 2021-03-31 | $802 |
| 2020-12-31 | $569 |
| 2020-09-30 | $187 |
| 2020-06-30 | $87 |
| 2020-03-31 | $81 |
| 2019-12-31 | $83 |
| 2019-09-30 | $55 |
| 2019-06-30 | $51 |
| 2019-03-31 | $50 |
| 2018-12-31 | $51 |
| 2018-09-30 | $53 |
| 2018-06-30 | $53 |
| 2018-03-31 | $53 |
| 2017-12-31 | $54 |
| 2017-09-30 | $55 |
| 2017-06-30 | $56 |
| 2017-03-31 | $55 |
| 2016-12-31 | $54 |
| 2016-09-30 | $17 |
| 2016-06-30 | $22 |
| 2016-03-31 | $0 |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2014-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.429B | $0.323B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |